Novonesis AS

Share Issue/Capital Change • Jan 24, 2017

On January 25, 2017, Novozymes will initiate a stock buyback program as
announced in Company announcement No. 1 of January 18, 2017. Under the program
Novozymes will buy back B shares worth up to DKK 2 billion in total during the
remainder of 2017, corresponding to around 8.1 million B shares at the current
share price. The program is contingent upon no major strategic initiatives
being decided upon that will require a significant amount of capital, for
example a major acquisition.

Read the full announcement in PDF